UK markets open in 7 hours 31 minutes

Zivo Bioscience, Inc. (ZIVO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.05-0.94 (-11.76%)
At close: 03:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.40M
Enterprise value 22.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)488.36
Price/book (mrq)21.13
Enterprise value/revenue 812.58
Enterprise value/EBITDA -3.09

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-57.04%
S&P500 52-week change 325.59%
52-week high 318.84
52-week low 30.48
50-day moving average 38.13
200-day moving average 36.70

Share statistics

Avg vol (3-month) 31.27k
Avg vol (10-day) 3800
Shares outstanding 52.8M
Implied shares outstanding 63.43M
Float 81.66M
% held by insiders 140.21%
% held by institutions 10.08%
Shares short (31 Oct 2023) 435.47k
Short ratio (31 Oct 2023) 46.65
Short % of float (31 Oct 2023) 42.61%
Short % of shares outstanding (31 Oct 2023) 42.04%
Shares short (prior month 29 Sept 2023) 412.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 327 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-16,072.75%

Management effectiveness

Return on assets (ttm)-338.92%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)27.65k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.78M
Diluted EPS (ttm)-4.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)274.38k
Total cash per share (mrq)0.1
Total debt (mrq)346.34k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.15
Book value per share (mrq)-0.93

Cash flow statement

Operating cash flow (ttm)-5.8M
Levered free cash flow (ttm)-2.86M